Cargando…
Histopathologic Features of Lymphedema: A Molecular Review
An estimated 5 million people in the United States are affected by secondary lymphedema, with most cases attributed to malignancies or malignancy-related treatments. The pathogenesis of secondary lymphedema has historically been attributed to lymphatic injury or dysfunction; however, recent studies...
Autores principales: | Li, Claire Y., Kataru, Raghu P., Mehrara, Babak J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177532/ https://www.ncbi.nlm.nih.gov/pubmed/32268536 http://dx.doi.org/10.3390/ijms21072546 |
Ejemplares similares
-
Inflammatory Manifestations of Lymphedema
por: Ly, Catherine L., et al.
Publicado: (2017) -
Abstract 120: Lymph Node Transplantation Decreases Local Immunosuppression In Lymphedema
por: Ly, Catherine L., et al.
Publicado: (2018) -
Abstract 9: Th2 Deficiency Attenuates The Pathologic Findings Of Lymphedema
por: Ly, Catherine L., et al.
Publicado: (2017) -
Doxycycline for the treatment of breast cancer-related lymphedema
por: Brown, Stav, et al.
Publicado: (2022) -
20. Skin Barrier Dysfunction in Lymphedema
por: Campbell, Adana, et al.
Publicado: (2023)